Please login to the form below

Not currently logged in
Email:
Password:

Q2 results

This page shows the latest Q2 results news and features for those working in and with pharma, biotech and healthcare.

Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb

Pfizer lifts 2021 guidance as sales of its BioNTech-partnered vaccine continue to climb

alone. In Q2, Pfizer’s revenues were up 86% operationally to $19bn – excluding sales of the BNT162b2 vaccine, revenues were still up 10% to $11bn.

Latest news

More from news
Approximately 20 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Interview: Joseph Jimenez, Novartis Interview: Joseph Jimenez, Novartis

    Our broad, yet focused,  portfolio delivered strong results in Q2, with sales growing 19 per cent. ... Consumer health grew five per cent in Q2, largely due to products like Theraflu and Voltaren.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...